• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

BioMarin Pharmaceutical Inc

+ Add to Watchlist


92.5300 USD 1.3100 1.40%

As of 11:58:38 ET on 12/22/2014.

Snapshot for BioMarin Pharmaceutical Inc (BMRN)

Open: 93.3400 Day's Range: 91.2000 - 93.8900 Volume: 462,710
Previous Close: 93.8400 52wk Range: 55.0400 - 96.3550 1-Yr Rtn: +33.84%

Stock Chart for BMRN

No chart data available.
  • BMRN:US 92.3150
  • 1D
  • 1M
  • 1Y
Interactive BMRN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BMRN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.1508
Est. EPS (USD) (12/2014) -0.8150
Est. PEG Ratio -
Market Cap (M USD) 13,780.66
Shares Outstanding (M) 147.47
30 Day Average Volume 1,237,239
Price/Book (mrq) 9.0076
Price/Sale (ttm) 20.0455
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BMRN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BMRN

BioMarin Pharmaceutical Inc. develops and commercializes therapeutic enzyme products. The Company has applied its proprietary enzyme technology to develop products for lysosomal storage diseases and for the treatment of serious burns. BioMarin's subsidiary provides analytical and diagnostic products and services in the area of carbohydrate biology.

Jean-Jacques BienaimeChief Executive OfficerDaniel K Spiegelman "Dan"Exec VP/CFO
Jeff AjerExec VP/Chief Commercial OfcrHenry J FuchsExec VP/Chief Medical Officer
More Company Profile & Key Executives for BMRN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil